Iovance Biotherapeutics
Peter A. Prieto, MD, MPH, CMQ, FACS, FSSO is currently serving as the Senior Vice President of Medical Affairs at Iovance Biotherapeutics, Inc. Peter A. is also the Founder & CEO of Prieto Medical, LLC, and works as a Consultant at Castle Biosciences, Inc. In addition, Peter A. holds multiple roles at the University of Rochester Medical Center including Adjunct Clinical Professor of Surgical Oncology, Associate Program Director of Research in General Surgery, and Director of Research in the Surgical Residency Program. Prior to their current positions, Peter A. has held various roles at institutions such as MD Anderson Cancer Center, Yale School of Medicine, National Cancer Institute (NCI), and SUNY Upstate Medical University. Peter A. Prieto is a highly experienced and accomplished individual in the field of surgical oncology.
This person is not in any offices
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.